GUILIN PHARMACEUTICAL CO., LTD.
Since the 1960s to now, it has been the largest pharmaceutical manufacturing enterprise in Guangxi Zhuang Autonomous Region all along, and has been listed as one of the key pharmaceutical enterprises of the state by China Pharmaceutical Industrial Association and China National Pharmaceutical Industrial Co., Ltd. Artesunate, a hi-tech product developed by the company with independent intellectual property rights has been approved as Class I new medicine by the Ministry of Health in 1987 with a patent for product invention, and in December 2005, it passed the supplier pre-qualification of WHO. The combination therapy of Artesunate plus Amodiaqiune is recommended by some authoritative organizations such as Global Roll Back Malaria Committee and WHO, and has obtained WHO and GMP certifications. Production lines for Bumetanide, Levamisol, Levamisole Phosphate also have passed the FDA quality verifications of the US.
Having experienced a century of pioneering and progressing, Guilin Pharmaceutical Co., Ltd has acquired good quality control systems and technical research and development abilities. Its distribution network covers all parts of the country. A number of its products are exported to more than 50 countries in Europe, America, Africa and Southeast Asia.
Southeast Asia; Africa; Western Europe;
500 - 1,000
50,000,000 - 100,000,000 UDS
No. 17 Shanghai Road, Guilin, Guangxi, China